spacer
home > news
INDUSTRY NEWS AND PRESS RELEASES

Aptar Pharma to Highlight Key Innovations Addressing Today’s Megatrends in Drug Delivery at CPHI Worldwide in Frankfurt, Germany

Aptar Pharma, a leading drug delivery systems provider, is pleased to once again be a main exhibitor at CPhI Worldwide 2017

More>>

 
phone +33 (0)13 917 2020
email info.pharma@aptar.com
web www.aptar.com/pharma
email 36-38 Rue de la Princesse, 78431 Louveciennes
 

Rentschler Biotechnologie GmbH Announces Transition into a European Corporation Called Rentschler Biopharma SE

Rentschler Biotechnologie GmbH announced that the Company has successfully transitioned into a European corporation (SE) with entry into the German commercial register on October 1, 2017

More>>

 
phone +49 7392 701-0
email info@rentschler.de
web www.rentschler.de
email Erwin-Rentschler-Str. 21, 88471 Laupheim
 

Bioclinica Moves to New Princeton, New Jersey Office in Response to Growth

New Jersey Lt. Governor Kim Guadagno, clients, partners, attend open house

More>>

 
phone +1 609-936-2896
email info@bioclinica.com
web www.bioclinica.com/
 

BBI Solutions adds more antibodies to product range

BBI Solutions has continued to invest in its portfolio of antibodies and today announced the launch of 10 infectious disease markers, 3 inflammatory markers, 2 fertility markers and an additional cardiac marker.

More>>

 
phone 08444 176393
email LauraBaker@bbisolutions.com
web www.bbisolutions.com
email 73 Ty Glas Avenue, Cardiff, CF14 5DX-
 

CPhI Worldwide to support International Medical Corps UK with global charity partnership

Collaboration to help raise funds, awareness and engagement from pharma community for the charity’s lifesaving work in crises across the globe

More>>

 
email cphi@ubm.com
email Frankfurt, Germany
 

CIDP Showcases Full Suite of Services at in-cosmetics North America 2017

Independent CRO Adds Ex Vivo Model to its Claims Substantiation Protocols

CIDP, Centre International de Développement Pharmaceutique, a Mauritius-based private and independent Contract Research Organisation (CRO), will bring its full suite of services – comprising research activities, in vitro and ex vivo testing, analytical chemistry, formulation, and clinical research – to in-cosmetics North America 2017. CIDP will also present its innovative anti-pollution and blue light study protocols, and reveal a new ex vivo model at the show. More>>

 
phone +230 401 2600
email info@cidp-cro.com
web www.cidp-cro.com/
email BioPark Mauritius, Socota Phoenicia, Sayed Hossen Road, Phoenix 73408, Mauritius
 

GE Healthcare opens its first European 3D printing and design center

New center in Uppsala, Sweden will apply 3D printing and other techniques to speed up innovation and simplify complex manufacturing processes

More>>

 
phone + 1 800 526 3593
email cs-us@ge.com
web www.gelifesciences.com
email P.O. Box 643065 Pittsburgh, PA 15264-3065 United States of America
 

RWS expands global offering with RWS Life Sciences.

The acquisition of LUZ, Inc. and Corporate Translations, Inc. strengthens RWS’ market leadership and continued growth of life science language services.

On October 1, 2017 RWS, the world's leading provider of translation, intellectual property, life sciences and language support services, announced a re-launch of its brand, website and divisional structure following a number of successful acquisitions which have significantly extended the group’s capabilities and geographical reach. More>>

 
phone +1 860 727 6000
web www.rws.com
email 77 Hartland St, East Hartford, CT 06108
 

New Study Demonstrates: WACKER’s Antioxidant HTEssence® Lowers LDL Cholesterol Significantly

Munich/Las Vegas, September 27, 2017

At Supply Side West 2017, WACKER is presenting new results on the effect of its nature-identical hydroxytyrosol HTEssence® on heart health. A recent human clinical study demonstrates that HTEssence® is able to significantly reduce LDL (low density lipoprotein) cholesterol. Reducing LDL has been found to support heart health. Hydroxytyrosol is a highly effective antioxidant found in olives with positive effects on blood pressure, joints and the immune and cardiovascular systems. WACKER is producing the first nature-identical hydroxytyrosol free of unwanted byproducts and with a defined amount of active ingredient. HTEssence® offers an excellent price/performance ratio and is easy to process in dietary supplements and functional beverages. WACKER will be exhibiting this product at SupplySide West in Las Vegas, Nevada (USA), from September 27-29, 2017. More>>

 
 

PCI Welcomes Al Moss as Philadelphia General Manager

PCI Pharma Services (PCI) is pleased to announce that Al Moss has assumed the role of Vice President and General Manager of its Philadelphia, PA location. The site serves as PCI’s corporate headquarters as well as a Center of Excellence for contract packaging services for commercial medicines, medical devices and consumer healthcare products. PCI operates an extensive global supply network across North America and Europe, supporting medicines destined to over 100 countries worldwide. More>>

 
 
spacer
News and Press Releases

Avacta and Mologic Enter Research and Product Development Collaboration Agreement

Avacta announces the formation of a collaborative research partnership
More info >>


White Papers

Syringe siliconization

Gerresheimer AG

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
More info >>

Industry Events

Cell Therapy Manufacturing & Gene Therapy Congress

6-7 December 2017, RAI, Amsterdam

Bringing together 300+ leaders and key influencers from pharma and biotech companies on 6 - 7 December 2017 in Amsterdam, Cell Therapy Manufacturing & Gene Therapy Congress will provide you with the latest advice for driving manufacturing and commercialisation through direct access to transforming innovative research to prosperous cell & gene manufacturing.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement